相关实验视频
Updated: Jan 29, 2026

07:16
Isolation of Cancer Stem Cells From Human Prostate Cancer Samples
Published on: March 14, 2014
14.6K
前列腺癌,JAK/STAT3失调和黄类药物:是否存在可能的联系?
Valentina Uivarosi1, Daniela Miricescu2, Ileana Adela Vacaroiu3
1Department of General and Inorganic Chemistry, Faculty of Pharmacy, Carol Davila University of Medicine and Pharmacy, 6 Traian Vuia Str., 020956 Bucharest, Romania.
International journal of molecular sciences
|January 28, 2026
概括
前列腺癌 (PC) 在全球范围内正在上升. 本综述探讨了PC风险因素,Janus激酶 (JAK) 信号转换器和转录 (STAT) 途径激活器.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 营养科学 营养科学
背景情况:
- 前列腺癌 (PC) 发病率在全球范围内不断增加,这对全球健康构成了重大挑战.
- 关键的PC风险因素包括遗传学,家族史,种族,饮食,肥胖,吸烟和感染.
- 简氏激酶 (JAK) 信号转换器和转录激活器 (STAT) 途径,特别是JAK/STAT3,与细胞生长,免疫调节和癌症发展有关,包括PC.
研究的目的:
- 审查目前与前列腺癌相关的发病率和风险因素.
- 阐明JAK/STAT3途径在PC病变发生过程中的作用,并讨论潜在的抑制剂.
- 通过影响JAK/STAT3通路来研究黄素作为治疗和预防PC的潜在作用.
主要方法:
- 文献综述综合了关于PC发病率,风险因素和JAK/STAT3信号通路的信息.
- 对JAK和STAT3抑制剂在癌症治疗中的现有研究进行分析.
- 检查关于黄类药物的抗癌性质的实验研究,特别是与PC和JAK/STAT3通路有关的实验研究.
主要成果:
- JAK/STAT3通路的失调有助于癌症的进展,包括促进PC的存活,血管生成和转移.
- 针对JAK和STAT3的抑制剂在临床前研究中已证明在抑制恶性细胞生长方面具有有效性.
- 一些天然的黄类化合物表现出抗炎,抗氧化和抗癌特性,有证据表明它们可以抑制PC的发展.
结论:
- JAK/STAT3通路是前列腺癌治疗干预的关键目标.
- 黄酸是一种有前途的自然化合物,有可能通过调节JAK/STAT3通路来预防和治疗PC.
- 对基于黄类药物的治疗方法的进一步研究可能会导致治疗前列腺癌的新策略.
相关概念视频
The JAK-STAT Signaling Pathway
12.4K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
12.4K
Covalently Linked Protein Regulators
9.4K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
9.4K
Covalently Linked Protein Regulators
2.0K
2.0K
X-linked Traits
58.6K
In most mammalian species, females have two X sex chromosomes and males have an X and Y. As a result, mutations on the X chromosome in females may be masked by the presence of a normal allele on the second X. In contrast, a mutation on the X chromosome in males more often causes observable biological defects, as there is no normal X to compensate. Trait variations arising from mutations on the X chromosome are called “X-linked”.
58.6K
Sex-linked Disorders
108.6K
Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.
108.6K
Enzyme-linked Receptors
86.5K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
86.5K

